| CURE
in the News ... more |
|
|
Connecticut
Has Earned A Respected Place But
Must Stay Alert in Competitive World of Biotech
From
the desk of Paul Pescatello, President and CEO of CURE
 CURE
recently attended stem cell and biotech meetings in
Philadelphia and San Diego. From these meeting it is clear
that Connecticut has
a recognized and respected niche in the high-stakes world of
cutting-edge bioscience. But it is also clear that the
competition in that world, for talent and investment dollars, has never been greater.
For
the full story |
|
Connecticut
Sends Its A Team to BIO Convention
 Connecticut
sent a powerhouse economic development team to BIO 2008 in
San Diego this year. The mission: to identify and open
conversations with business executives considering options
for relocating, expanding, or starting up a lifescience
company. This year more than 20,000 industry executives from
all over the world met in San Diego for three days of
meetings, seminars, and other activities.
For
the full story |
|
Yale
Stem Cell Talk Draws Capacity Audience
 A capacity crowd packed the main auditorium of
Yale's Anlyan Center June 18 for an informal lunchtime
presentation, "Stem Cells: Everything You Wanted to Know But Were Afraid to Ask." Presenting were Haifan Lin, Ph.D., director of the Yale Stem Cell Center and Robert
Mandelkern, Connecticut state coordinator of the Parkinson's Action Network and a member of the
Connecticut State Stem Cell Research Advisory Committee.
For
the full story |
|
CURE
Member News Digest
 454
Life Sciences installs
sequencer at Delhi Institute
Achillion
announces Phase 2 results
Alexion
reports fatigue data for PNH patients
Applied
Spine
enrolls
100th patient in Stabilimax NZ® study
Bayer
HealthCare reports Leukine® results
Boehringer
Ingelheim describes female sexual disorder
Bristol-Myers
Squibb announces ORENCIA® results
Cantor
Colburn adds intellectual property attorneys
CuraGen
treats
first patient in Phase 2 breast cancer study
Danbury
Hospital performs ankle replacement
Genomas
creates digital collage
GlaxoSmithKline
acquires Sirtris
HistoRx
technology at Dana-Farber
Ipsogen
enters breast cancer diagnostic market
Johnson
& Johnson subsidiary wins psoriasis
approval
NanoViricides
posts kerato-conjunctivitis results
Neurogen suspends
insomnia study
Pfizer
names oncology general manager
PhRMA
seeks more funding for FDA
Protein
Sciences rebuts allegations by Emergent
BioSolutions
Quinnipiac
University announces Lord appointment
Rib-X announces
skin infection drug trials
Triumvirate
Environmental a "best place to work"
Vion presents
Cloretazine® data
UConn
TIP program provides lab space in Farmington
Yale
hires James Rothman, cell biologist
For
the full story |
|
